Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q2 2016 · 10-Q
Revenue—
Net Income-$10.86M-$10.86MN/M vs Q2 2015 EPS Diluted-$3.97-$3.97N/M vs Q2 2015 Operating Cash Flowderived-$11,241,000N/M Free Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
derived
ended Jun 30, 2016 · filed Aug 4, 2016 · 35 d after period end